[1]Ibrahim N,Yu Y,Walsh WR,et al. Molecular targeted therapies for cancer: sorafenib mono-therapy and its combination with other therapies (review).Oncology reports, 2012,27(5):1303-1311. [2]Strumberg D.Sorafenib for the treatment of renal cancer.Expert Opin Pharmacother,2012,13(3):407-419. [3]Woo HY, Heo J. Sorafenib in liver cancer.Expert Opin Pharmacother,2012,13(7):1059-1067. [4]Mertens JC,Martin IV,Schmitt J.et al. Multikinase inhibitor sorafenib transiently promotes necrosis after radiofrequency ablation in rat liver but activates growth signals.Eur J Radiol,2012,81(7):1601-1606.